IBEX (IBEX) Q2 2026: Health Tech Surges 35%, Shifting Margin and Growth Mix
IBEX’s second quarter saw health tech and digital services drive a 17% revenue jump, with AI-powered solutions and India expansion anchoring margin growth and competitive separation. Leadership’s focus on high-margin verticals and geographies is reshaping the business mix, while increased capital allocation to AI and offshore capacity signals further transformation ahead. Guidance was raised on both top and bottom lines, reflecting management’s confidence in sustained outperformance and operational leverage.
Summary
- Health Tech Expansion: Health tech vertical accelerated as a key growth and margin engine.
- AI and Offshore Scaling: AI-first strategy and India buildout are transforming IBEX’s operating model.
- Guidance Raised: Leadership sees sustained margin and revenue momentum into the second half.
Business Overview
IBEX is a business process outsourcing (BPO) provider specializing in customer experience (CX) solutions for industries including health tech, fintech, retail, e-commerce, travel, and telecommunications. The company generates revenue through outsourced contact center operations, digital acquisition services, and AI-powered omnichannel solutions, delivered via offshore, nearshore, and onshore centers. Its fastest-growing segments are high-margin verticals like health tech and digital services, with a strategic focus on expanding AI capabilities and offshore delivery.
Performance Analysis
IBEX delivered a fourth consecutive quarter of double-digit organic revenue growth, with total revenue up 16.7% year over year, driven by a 35% surge in the health tech vertical and double-digit gains in travel, logistics, and retail/e-commerce. The mix shift away from legacy telecommunications (now under 9% of revenue) to higher-margin verticals is reshaping both top-line momentum and profitability. Digital and omnichannel services now account for 82% of total revenue, up 19% YoY, demonstrating the pivot toward scalable, tech-enabled offerings.
Profitability improvements were anchored by operating leverage, as SG&A expenses declined to 16.8% of revenue from 18.3%. Offshore revenue, representing over half the business, grew 16%, while onshore expansion (up 27.5%) was fueled by digital acquisition services. Adjusted EBITDA margin expanded by 80 basis points to 12.6%, underpinned by growth in high-margin geographies and services. Capital expenditures rose to 7.1% of revenue, reflecting investment in new offshore capacity, particularly in India, where IBEX has rapidly scaled to 1,000 agents in less than a year.
- Health Tech Outperformance: Health tech now contributes 17.4% of revenue, up from 15.1%, and is on pace to hit $100 million this year.
- Client Concentration Management: Largest client is 10% of revenue, with top 5 at 39%, reflecting disciplined diversification.
- Cash Flow and CapEx: Operating cash flow hit a quarterly record, but free cash flow was negative due to planned CapEx for offshore buildout.
Overall, IBEX’s results reflect a deliberate shift toward higher-growth, higher-margin verticals and geographies, with AI and digital services as structural differentiators. The business is executing on both new client wins and embedded base expansion, positioning for sustainable outperformance as legacy segments recede.
Executive Commentary
"Our market leading growth is a direct result of the differentiation we have built into our business and our ability to execute against it. Our growth starts with our new logo engine, which consistently is able to win trophy clients versus our much bigger competitors. In Q2, we had significant wins in health tech and fintech. Health tech has been a standout performer, growing rapidly since we launched the vertical in 2021, and is on track to become 100 million by the end of the fiscal year. This success demonstrates our ability to build and scale new verticals from the ground up."
Bob Dekken, Chief Executive Officer
"Our higher margin digital and omnichannel services continues to strengthen, growing 19% versus the prior year quarter to 82% of our total revenue. We have structurally built IBEX so that our growth vectors are our highest margin regions and services, and we expect that we will continue to be successful in driving growth in these higher margin regions and services as new client wins and growth in our embedded base continue to be focused in these areas."
Taylor, Chief Financial Officer
Strategic Positioning
1. AI-First CX Transformation
IBEX’s Wave IX AI solution, which integrates agentic AI with human agents, is central to its market positioning as an AI-powered CX leader. The company is investing in both client-facing AI deployments and internal automation (hiring, training, onboarding) to drive operational efficiency and client outcomes. The promotion of a Chief AI and Digital Officer underscores the priority placed on this transformation.
2. Health Tech and Vertical Diversification
Rapid scaling in health tech is not only driving revenue growth but also margin expansion, as the vertical’s economics are superior to legacy telecom and retail. IBEX’s ability to build new verticals from scratch and scale them to material contributors is emerging as a repeatable playbook, with fintech and travel/logistics also showing strong momentum.
3. Offshore and India Expansion
The strategic push into India, with two sites and 1,000 agents launched in under a year, is creating a new high-growth, high-margin geography for IBEX. This expansion supports both new client acquisition and embedded client growth, particularly in healthcare, and is expected to be a key margin lever as scale improves.
4. Digital and Omnichannel Services
Digital acquisition and omnichannel services now comprise the majority of revenue, reflecting a business model shift toward more scalable, tech-enabled solutions. This segment’s growth is supported by both onshore and offshore delivery, with onshore mix rising due to digital service demand.
5. Capital Allocation and Balance Sheet Strength
IBEX’s net cash position and ongoing share repurchase program provide flexibility to invest in growth initiatives, AI, and capacity expansion without balance sheet strain. The company is strategically deploying capital to support high-return projects while maintaining disciplined client concentration and risk management.
Key Considerations
This quarter marks a clear inflection in IBEX’s business mix, with health tech and AI-powered services now firmly established as the primary growth and margin engines. The company’s ability to rapidly scale new verticals and geographies, while maintaining operational leverage and client diversification, is central to its competitive positioning.
Key Considerations:
- AI Differentiation as Client Magnet: IBEX’s AI capabilities are driving new client wins and deeper wallet share with existing clients, particularly in health tech and fintech.
- India Ramp Still in Investment Phase: Margins in India are not yet at target levels, but management expects improvement as scale and operational maturity increase.
- CapEx and Free Cash Flow Trade-Off: Elevated capital expenditures are necessary to support offshore and digital growth, temporarily pressuring free cash flow.
- Telecom Decline Reduces Legacy Drag: Telecommunications now below 9% of revenue, lessening exposure to a structurally challenged segment.
- Client Concentration Well Managed: Largest client at 10% and top 25 at 79% of revenue, showing diversification even as new verticals scale.
Risks
IBEX’s aggressive investment in AI and offshore capacity brings execution risk, especially as India ramps and health tech scales rapidly. Margin expansion is contingent on successful operationalization of new geographies and continued demand for digital/AI services. Industry disruption from generative AI, client insourcing, or macroeconomic headwinds could impact growth vectors, while elevated CapEx may constrain free cash flow if revenue growth slows.
Forward Outlook
For Q3 2026, IBEX guided to:
- Continued double-digit revenue growth, with health tech and digital as primary drivers
- Ongoing margin expansion as offshore and AI initiatives mature
For full-year 2026, management raised guidance:
- Revenue of $620 to $630 million (up from $605 to $620 million)
- Adjusted EBITDA of $80 to $82 million (up from $78 to $81 million)
Management highlighted several factors that support the outlook:
- Strong embedded base growth and new client wins in high-margin verticals
- Strategic investments in AI and offshore capacity expected to yield further margin gains
Takeaways
IBEX’s Q2 results reinforce its transformation from a traditional BPO to an AI-powered, vertical-focused CX leader.
- Business Mix Shift: Health tech and digital now anchor growth and margin, de-risking legacy segments and enabling operational leverage.
- AI and Offshore Execution: Leadership’s AI-first strategy and rapid India buildout are driving competitive separation and margin expansion, but require continued flawless execution.
- Watch for Margin Realization: Investors should monitor the trajectory of India margins, AI client adoption, and free cash flow conversion as CapEx remains elevated.
Conclusion
IBEX is successfully pivoting to higher-growth, higher-margin verticals and AI-enabled services, with health tech and digital at the core of its new operating model. Management’s raised guidance and disciplined execution underscore confidence in sustained outperformance, though continued investment in AI and offshore scaling will be key to realizing the full margin and growth potential.
Industry Read-Through
IBEX’s results highlight a broader shift in the BPO and CX industry toward AI-first, verticalized solutions and away from legacy telecom and commodity contact center services. The rapid scaling of health tech and digital acquisition reflects secular trends favoring specialized, tech-enabled outsourcing partners. Competitors with legacy-heavy portfolios or lagging AI capabilities may face margin compression and client attrition, while those able to build and scale new verticals—especially in health tech and fintech—will set the pace for industry transformation. IBEX’s India expansion is also a signal that offshore capacity remains a key lever for margin and cost competitiveness as the CX landscape evolves.